Search F2 TechNotes
Categories
- ASCA Program
- ATEX Directive 2014/34/EU
- CE marking
- Consulting
- EMC Directive 2014/30/EU
- EN 60601-1
- FCC
- FDA
- General Product Safety Directive 2001/95/EC
- IP Testing
- Lasers
- Listing
- Low Voltage Directive 2014/35/EU
- Machinery Directive 2006/42/EC
- Machinery Regulation (EU)2023/1230
- Medical Devices Regulation (EU)2017/745
- PPE Regulation (EU) 2016/425
- Pressure Equipment Directive 2014/68/EU
- Product Testing
- Prop 65
- R&TTE Directive 1999/5/EC
- Radio Equipment Directive 2014/53/EU
- REACH
- RoHS Directive 2011/65/EU
- UKCA
- UL 60335-1
- UL 61010-1
- UL 62368-1
- UL 94
-
Recent Posts
- So You Need a Field Evaluation?
- How to Navigate California Proposition 65
- Breaking Down California’s New Proposition 65 Labeling Guidelines
- The Wacky World of Exempted Devices: What You Don’t Need to Worry About
- Cracking the Code: Surviving the FDA’s AI-Enabled Medical Device Guidance (With Sanity Intact)
Author Archives: Cristina Akinwale
Easy Approach to Essential Performance in Medical Devices for FDA
F2 Labs has many conversations every week with medical device manufacturers who are struggling to define Essential Performance for their device. From our experience, the confusion around Essential Performance frequently stems from the fact that what a device manufacturer views … Continue reading
Posted in CE marking
Comments Off on Easy Approach to Essential Performance in Medical Devices for FDA